Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 14,353-14,364 of 23,847
Drug study icon
TerminatedNCT03768726

Safety study of flexible Doses Of Oral Ziprasidone in Bipolarity

This study was terminated in the United States. It is testing flexible Doses Of Oral Ziprasidone for Bipolarity.

Multiple locations, including Orange City
BipolarityDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
Drug study icon
TerminatedNCT03121586

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

This study exists to understand how the medication Pimavanserin holds up over time after the earliest research stage. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Phoenix
SchizophreniaDrugOver 18 Years
Countries
United States, Canada, Argentina, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
TerminatedNCT01121536

Safety and Efficacy of Armodafinil Treatment for depression

This study was terminated in the United States, in Australia, in France, .... It is testing safety and Efficacy of Armodafinil Treatment for depression.

Multiple locations, including Birmingham
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.